查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010028

内视镜市场：2026-2032年全球市场预测（以内视镜类型、易用性、影像技术、最终用户和应用划分）

Endoscopy Market by Endoscope Type, Usability, Imaging Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年内视镜市场价值 469.2 亿美元，预计到 2026 年将成长至 504.5 亿美元，复合年增长率为 7.99%，到 2032 年将达到 803.9 亿美元。

主要市场统计数据
基准年 2025 469.2亿美元
预计年份：2026年 504.5亿美元
预测年份 2032 803.9亿美元
复合年增长率 (%) 7.99%

为因应临床需求、设备创新、安全要求和采购压力，策略性因应措施正在重塑内视镜的引进和采购决策过程。

内视镜医学的现状正处于快速技术创新、临床重点转变以及对安全性和成本效益日益严格的监管三者交汇的阶段。影像技术、一次性器材设计和感染控制方面的进步正在改变临床医生选择设备的方式，以及医疗系统管理资本投资和营运成本的方式。随着微创手术在各专科的诊断和治疗路径中不断占据基础，内视镜技术必须应对更严格的工作流程、不断提高的诊断准确性要求以及不断变化的监管环境。

技术整合、以安全为中心的产品设计以及供应链韧性如何重新定义内视镜领域的竞争格局和临床应用。

在内镜领域，正在发生多项变革性变化，这些变化正在全面重塑竞争优势和应用路径。首先，一次性技术与可重复使用可用技术之间的平衡不再是阶段性选择，而是影响製造地、服务模式和临床工作流程的策略轴心。一次性器材在设计和成本效益方面取得了进步，为旨在减轻再处理负担和降低感染传播风险的医疗机构创造了新的服务和采购模式。同时，影像技术、感测器精度和软体改进方面的进步提高了诊断的可靠性，并推动了基于远端医疗的影像诊断的发展。

本分析检视了美国新关税措施对医疗设备製造商和供应商的供应链、筹资策略和商业决策的策略性连锁反应。

美国于2025年宣布的一系列关税政策调整，正对内视镜产业生态系统产生广泛的下游影响。关税导致的接收成本变化，影响製造商、医院采购部门和第三方服务供应商，迫使相关人员重新评估筹资策略和营运模式。对于依赖国际供应链的医疗设备製造商而言，关税政策直接促使他们重新审视零件采购管道，对新的供应商进行认证，或考虑将关键前置作业时间的生产外包到近岸地区，以降低进口风险并提高交货週期的可预测性。

详细的细分洞察解释了设备类型、易用性、成像系统、医疗环境和临床应用如何共同决定采购和开发重点。

细分市场趋势揭示了临床需求与技术能力的交会点，从而在不同的产品线和医疗环境中创造了差异化的机会。在评估内视镜类型时，市场将内视镜分为软式内视镜（包括支气管镜、大肠镜、膀胱镜、十二指肠镜和胃镜）和硬式内视镜（包括关节镜、子宫镜和腹腔镜）。临床专科和手术量决定了医疗设备的需求。对于软式内视镜，导航、镜端影像品质和用于治疗性介入的通道功能是优先考虑的因素；而对于硬式内视镜，手术环境下的光学清晰度、器械相容性和耐用性则更为重要。这些技术需求指南设计权衡和服务交付，製造商针对每种亚型最佳化灭菌相容性和配件生态系统。

区域趋势和部署模式表明，美洲、欧洲、中东和非洲以及亚太地区都需要各自独特的商业化、供应和服务策略。

区域趋势影响全球内视镜市场的需求模式和竞争格局。在美洲，医疗保健整合、报销结构以及对价值医疗的重视，推动了人们对能够提高诊断准确性并降低总手术成本的解决方案的兴趣。安全性和可追溯性方面的监管预期，以及大规模的集中化（这些机构制定了采购标准），也影响着内视镜技术的普及趋势。因此，能够提供整合服务模式和显着感染控制优势的公司，在采购谈判中往往更具优势。

竞争策略揭示了产品差异化、整合服务模式和数数位化如何塑造供应商定位和伙伴关係活动。

医疗设备製造商和服务供应商之间的竞争围绕着三大核心提案：产品性能差异化、服务和灭菌能力，以及数位化转型。主要企业正投资于新一代光学技术、人体工学设计和通道多功能性，以提高诊断准确性和治疗效率。他们也在拓展服务和再处理解决方案，以解决医疗服务提供者在处理能力、合规性和生命週期管理方面的担忧。这种硬体与服务相结合的模式，透过维护和耗材供应合同，加强了客户关係并创造了持续的收入。

为製造商和医疗保健系统领导者提供切实可行的策略行动，以保护供应链、加速临床部署并创造可持续的商业性优势。

产业领导者应优先采取一系列具体行动，将策略洞察转化为可衡量的成果。首先，应实现采购和供应链策略多元化，以减轻贸易政策干扰的影响，并缩短关键零件的前置作业时间。关键模组的近岸外包和双重采购可以保持灵活性，并抵御突如其来的关税和物流中断。其次，应加快开发和临床检验能够解决感染预防和再处理效率问题的解决方案，因为这些特性正日益影响所有医疗机构的采购决策。

一项稳健的混合方法研究，结合了初步的临床和采购访谈、严格的二次分析和迭代的专家检验。

本执行摘要基于一项研究，该研究结合了对该领域专家的结构化一手访谈、对临床文献和监管指南的系统性回顾，以及对供应商和医疗服务提供者数据的检验，以检验研究结果。主要资讯来源包括对临床医生、医院和门诊中心的采购经理以及医疗设备製造商和分销商的高阶主管的访谈。这些对话对医疗器材的推广应用驱动因素、临床限制和采购优先事项进行了定性评估。

结论强调，临床创新、监管合规和强有力的商业化之间的协调一致，将决定内视镜领域的长期成功。

目前内视镜领域既充满机会也面临挑战。影像技术、医疗设备设计和数位分析技术的进步正在拓展临床应用能力，并为提高诊断准确性铺平道路。同时，安全问题、监管以及贸易政策的变化使得供应链韧性、生命週期思维和服务卓越性变得至关重要。医疗机构和製造商若能积极将产品创新与营运实际情况结合，尤其是在设备再处理能力、检测处理能力和本地采购惯例，将取得最佳的应用效果。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜市场：以内视镜类型划分

  • 软式内视镜
    • 支气管镜检查
    • 大肠镜检查
    • 膀胱镜
    • 十二指肠内视镜检查
    • 胃镜检查
  • 硬式内视镜
    • 关节镜
    • 子宫镜
    • 腹腔镜

第九章：内视镜市场：依易用性划分

  • 一次性的
  • 可重复使用的

第十章：依影像技术分類的内视镜市场

  • 光纤内视镜
  • 影像内视镜

第十一章 内视镜市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十二章 内视镜市场：依应用领域划分

  • 消化系统
  • 妇科
  • 呼吸系统
  • 泌尿系统

第十三章 内视镜市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 内视镜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 内视镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国内视镜市场

第十七章：中国内视镜市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Mindray Medical International Limited
  • Olympus Corporation
  • Pentax Medical Company
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • STERIS Corporation
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-434CCDA04E9F

The Endoscopy Market was valued at USD 46.92 billion in 2025 and is projected to grow to USD 50.45 billion in 2026, with a CAGR of 7.99%, reaching USD 80.39 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 46.92 billion
Estimated Year [2026] USD 50.45 billion
Forecast Year [2032] USD 80.39 billion
CAGR (%) 7.99%

A strategic orientation to clinical needs, device innovation, safety imperatives, and procurement pressures that are reshaping endoscopy adoption and purchasing decisions

The modern endoscopy landscape sits at the convergence of rapid technological innovation, shifting clinical priorities, and heightened scrutiny around safety and cost-effectiveness. Advances in imaging, single-use device design, and infection prevention are changing the way clinicians choose instruments and how health systems manage capital and operational expenditures. As minimally invasive procedures continue to anchor diagnostic and therapeutic pathways across specialties, endoscopy technologies must respond to tighter workflows, greater demand for diagnostic accuracy, and evolving regulatory expectations.

Clinicians and administrators increasingly prioritize solutions that reduce procedural complexity and mitigate cross-contamination risk while preserving or enhancing image quality and therapeutic capability. Consequently, manufacturers are accelerating product upgrades that improve ergonomics, integrate digital imaging and analytics, and simplify reprocessing. At the same time, providers are balancing those clinical benefits with procurement realities, supply chain resilience, and lifecycle cost considerations. Together, these forces create a dynamic environment where device performance, infection control credentials, service infrastructure, and supply assurance influence procurement and adoption decisions.

Understanding these dynamics requires a holistic view of clinical need, device technology, and operational constraints. This report frames the critical intersections between clinical utility and commercial strategy, emphasizing practical implications for manufacturers, hospital systems, ambulatory centers, and clinical teams. By focusing on actionable intelligence that connects innovation to adoption enablers, the analysis highlights where investments and strategic shifts deliver the greatest clinical and economic returns.

How technological integration, safety-driven product design, and supply chain resilience are jointly redefining competitive models and clinical adoption in endoscopy

The endoscopy field is undergoing several transformative shifts that collectively reconfigure competitive advantage and adoption pathways. First, the balance between single-use and reusable technologies is no longer an incremental choice but a strategic axis that affects manufacturing footprints, service models, and clinical workflows. Single-use devices have advanced in design and cost-effectiveness, prompting new service and procurement models in facilities that aim to lower reprocessing burden and infection transmission risk. In parallel, improvements in video imaging, sensor fidelity, and software-driven enhancement are elevating diagnostic confidence and enabling telemedicine-enabled interpretations.

Second, integration of digital health capabilities is accelerating. Real-time image analytics, artificial intelligence-assisted lesion detection, and cloud-based case management systems are shifting value from hardware alone toward software-enabled diagnostic ecosystems. These shifts create opportunities for vendors to expand recurring revenue streams through software licensing, data services, and outcome-based contracting. Third, regulatory and reimbursement environments have tightened attention on safety, traceability, and environmental impact, prompting manufacturers and providers to re-evaluate lifecycle costs and cleaning protocols. Finally, supply chain resilience has moved to the forefront of strategic planning. Manufacturers and buyers are diversifying sourcing strategies, adopting dual-sourcing approaches, and re-examining onshore manufacturing to mitigate tariff exposure and logistics disruptions.

Taken together, these shifts mean that technical performance, digital integration, safety credentials, and supply assurance now determine market momentum. Strategic players that align product innovation with robust service and supply-chain propositions will find differentiated adoption opportunities across clinical settings.

Analyzing the strategic ripple effects of new U.S. tariff measures on supply chains, procurement strategies, and the operational calculus of device manufacturers and providers

The cumulative policy adjustments introduced through the United States tariffs announced in 2025 have broad downstream implications for the endoscopy ecosystem. Tariff-induced changes in landed costs affect manufacturers, hospital purchasing departments, and third-party service providers, compelling stakeholders to reassess sourcing strategies and operational models. For device producers reliant on transnational supply chains, tariffs create immediate incentives to review component sourcing, qualify new suppliers, or consider near-shoring for critical subassemblies to reduce import exposure and improve lead-time predictability.

Health systems and ambulatory providers respond to tariff-driven cost pressures through procurement levers, including renegotiated service agreements, longer-term purchase commitments, and a heightened focus on total cost of ownership rather than initial acquisition price. Capital-constrained facilities may delay elective upgrades or accelerate adoption of single-use products where reprocessing cost and sterilization capital make a compelling offset to import-related cost increases. At the same time, independent third-party service organizations and distributors adjust pricing and contractual terms to preserve margin while managing inventory risks and longer replenishment cycles.

Regulatory compliance and documentation burdens increase as manufacturers and providers validate alternative supplier sources and manufacturing locations. This process can extend time-to-market for new devices and complicate post-market surveillance. Yet, the tariff environment also stimulates strategic realignment: organizations that invest in regional manufacturing capability or stronger supply diversification gain competitive advantage through improved cost predictability and responsiveness. In short, tariffs amplify the need for agile procurement, deeper supplier collaboration, and portfolio strategies that account for evolving trade policy risks.

Deep segmentation insights explaining how device type, usability, imaging systems, care setting, and clinical application jointly determine procurement and development priorities

Segment-level dynamics reveal where clinical demand and technology capability intersect to create differentiated opportunities across product lines and care settings. When evaluating endoscope type, the market differentiates between flexible endoscopes, which include bronchoscopes, colonoscopes, cystoscopes, duodenoscopes, and gastroscopes, and rigid endoscopes, which encompass arthroscopes, hysteroscopes, and laparoscopes. Clinical specialties and procedural volumes shape device requirements: flexible endoscopes prioritize navigation, distal imaging quality, and channel functionality for therapeutic interventions, while rigid endoscopes emphasize optical clarity, instrument compatibility, and durability in operative environments. These technical needs inform design trade-offs and service offerings, with manufacturers tailoring sterilization compatibility and accessory ecosystems to each subtype.

Usability considerations-disposable versus reusable-drive procurement and operational choices across facilities. Disposable endoscopes reduce reprocessing complexity and mitigate cross-contamination concerns, making them attractive for lower-volume sites or procedures with high infection-control sensitivity. Conversely, reusable devices continue to appeal where durability, higher-performance optics, and cost amortization over repeated use align with institutional case-mix and sterilization capacity. The interplay between usability and imaging technology is critical: fiber optic systems retain advantages in specific legacy applications, whereas video endoscopy platforms enable higher-resolution imaging, easier integration with digital analytics, and smoother clinician adoption for image-driven diagnostics.

End users-ambulatory surgical centers, clinics, and hospitals-exhibit distinct procurement behaviors and clinical workflows that influence device selection. Ambulatory surgical centers often prioritize throughput, simplified reprocessing, and lower up-front capital, while clinics may emphasize portability and single-procedure cost-effectiveness. Hospitals routinely require comprehensive service agreements, interoperable IT integration, and devices that support a wide procedural spectrum. Across applications-gastrointestinal, gynecological, respiratory, and urological-the degree of therapeutic intervention, instrument channel needs, and imaging demands vary, which in turn shapes product road maps and aftermarket service propositions. Ultimately, success depends on aligning device attributes with procedural requirements, reprocessing infrastructure, and the economic model of each care setting.

Regional dynamics and adoption patterns showing how the Americas, Europe Middle East & Africa, and Asia-Pacific each demand tailored commercialization, supply, and service strategies

Regional dynamics shape both demand patterns and competitive positioning across the global endoscopy landscape. In the Americas, provider consolidation, reimbursement structures, and an emphasis on value-based care drive interest in solutions that reduce total procedural cost while improving diagnostic yield. Adoption is influenced by regulatory expectations around safety and traceability, as well as by a concentrated base of large hospital systems and ambulatory networks that set procurement standards. Consequently, companies that offer integrated service models and clear infection-control advantages tend to gain traction in procurement discussions.

Europe, Middle East & Africa presents a heterogeneous environment where regulatory frameworks, reimbursement pathways, and infrastructure maturity vary significantly across countries. In several markets, robust public healthcare procurement processes elevate the importance of long-term service agreements and compliance credentials. Elsewhere, demand growth hinges on expanding access to minimally invasive care and upgrades to diagnostic infrastructure. Manufacturers must navigate diverse regulatory regimes while tailoring market access strategies to local procurement cycles and clinical training initiatives.

Asia-Pacific exhibits accelerated adoption driven by capacity expansion, increased procedural volumes, and investments in medical infrastructure. A growing domestic manufacturing base in parts of the region enhances local supply options, and rapid uptake of new technologies frequently follows strong clinical advocacy and targeted training programs. Across all regions, differences in procurement cadence, clinical practice patterns, and regulatory timelines require nuanced commercialization strategies that balance global product platforms with localized service and supply commitments.

Competitive strategies reveal how product differentiation, integrated service models, and digital enablement are shaping vendor positioning and partnership activity

Competitive behavior among device manufacturers and service providers centers on three core propositions: product performance differentiation, service and sterilization capability, and digital enablement. Leading firms invest in next-generation optics, ergonomics, and channel versatility to improve diagnostic yield and procedural efficiency. They also expand service footprints and reprocessing solutions to address provider concerns about throughput, compliance, and lifecycle management. This combined hardware-plus-service approach strengthens customer relationships and creates recurring revenue through maintenance contracts and consumable supply agreements.

A parallel strategic thrust focuses on software and analytics. Companies that integrate image enhancement tools, workflow orchestration, and case management platforms differentiate by delivering measurable gains in clinician productivity and diagnostic consistency. Partnerships with software specialists and clinical research organizations underpin these moves and accelerate time-to-value. Additionally, several competitors are broadening their portfolios through strategic alliances, targeted acquisitions, and joint go-to-market agreements to secure access to complementary technologies and expand distribution reach.

Finally, sustainability and environmental considerations are emerging as differentiators. Organizations that demonstrate life-cycle thinking-addressing device recyclability, reprocessing efficiency, and waste reduction-gain favor with purchasers that have institutional sustainability mandates. Competitive advantage accrues to companies that combine credible environmental initiatives with clear clinical and economic benefits.

Practical strategic actions for manufacturers and health system leaders to protect supply chains, accelerate clinical adoption, and create enduring commercial advantage

Industry leaders should prioritize a set of concrete actions that translate strategic insight into measurable outcomes. First, diversify sourcing and supply-chain strategies to reduce exposure to trade policy disruptions and to shorten lead times for key components. Near-shoring or dual-sourcing critical modules can preserve agility and protect against sudden tariff or logistics shocks. Second, accelerate development and clinical validation of solutions that address infection prevention and reprocessing efficiency, as these attributes increasingly influence procurement decisions across care settings.

Third, invest in software-enabled differentiation that complements hardware innovation; deploying analytics and workflow tools increases clinical utility and creates recurring revenue opportunities. Fourth, refine commercial models to align with buyer priorities: offer bundled service agreements, outcome-linked contracts, and scalable pricing that reflect the total cost of ownership for differing facility types. Fifth, strengthen relationships with ambulatory surgical centers and clinics through targeted training, service packages, and financing options to drive adoption outside tertiary hospitals. Sixth, engage proactively with regulators and key opinion leaders to streamline approvals and build clinical evidence that demonstrates safety, efficacy, and economic benefit. Finally, incorporate environmental lifecycle management into product design and corporate strategy to meet emerging sustainability expectations without compromising clinical performance.

Taken together, these actions help manufacturers and providers mitigate risk, seize adoption opportunities, and build resilient, differentiated propositions that match the evolving needs of clinicians and healthcare systems.

Robust mixed-method research combining primary clinical and procurement interviews with rigorous secondary analysis and iterative expert validation

The research underpinning this executive summary combined structured primary engagement with domain experts, systematic review of clinical literature and regulatory guidance, and triangulation of supplier and provider data to validate findings. Primary inputs included interviews with practicing clinicians, procurement leaders at hospitals and ambulatory centers, and senior executives in device manufacturing and distribution. These conversations informed qualitative assessments of adoption drivers, clinical constraints, and procurement priorities.

Secondary research synthesized peer-reviewed clinical studies, regulatory announcements, and technical standards that govern device design and cleaning protocols. Where appropriate, comparative product assessments and case studies were used to illustrate performance differentials, while attention to public policy and trade updates framed assessment of supply-chain risks. Findings were validated through iterative review cycles with external clinical advisors and industry practitioners to ensure practical relevance and factual accuracy. Limitations include variability in regional regulatory timelines and heterogeneity of procurement practices across facility types; the methodology addresses these by applying conservative extrapolation and by noting context-specific constraints within the analysis.

Quality assurance steps included cross-checking interview insights against documented device specifications and reprocessing standards, and confirming thematic consistency across multiple data sources. The research approach emphasizes actionable synthesis over purely quantitative projection, aiming to equip decision-makers with defensible evidence and clear strategic implications.

Concluding synthesis highlighting how alignment of clinical innovation, reglementary compliance, and resilient commercialization will determine long-term success in endoscopy

The current era of endoscopy is defined by a balance of opportunity and constraint. Technological advances in imaging, device design, and digital analytics expand clinical capability and open routes to improved diagnostic accuracy. At the same time, safety concerns, regulatory scrutiny, and trade policy shifts place a premium on supply-chain resilience, lifecycle thinking, and service excellence. Providers and manufacturers that proactively align product innovation with operational realities-particularly reprocessing capacity, procedural throughput, and regional procurement practices-will realize the greatest adoption gains.

Success depends on integrating clinical insight with pragmatic commercial strategies: design devices for the actual workflows of ambulatory centers, clinics, and hospitals; pair hardware with software and service offerings that demonstrate clear value; and build flexible sourcing models that withstand policy and logistics variability. Those who act now to reconcile clinical benefits with procurement and regulatory demands will be best positioned to capture emerging opportunities and to lead the next phase of endoscopy advancement. In short, the path forward rewards organizations that blend technical excellence with operational foresight and strong customer partnerships.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopy Market, by Endoscope Type

  • 8.1. Flexible Endoscopes
    • 8.1.1. Bronchoscopes
    • 8.1.2. Colonoscopes
    • 8.1.3. Cystoscopes
    • 8.1.4. Duodenoscopes
    • 8.1.5. Gastroscopes
  • 8.2. Rigid Endoscopes
    • 8.2.1. Arthroscopes
    • 8.2.2. Hysteroscopes
    • 8.2.3. Laparoscopes

9. Endoscopy Market, by Usability

  • 9.1. Disposable
  • 9.2. Reusable

10. Endoscopy Market, by Imaging Technology

  • 10.1. Fiber Optic Endoscopy
  • 10.2. Video Endoscopy

11. Endoscopy Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Endoscopy Market, by Application

  • 12.1. Gastrointestinal
  • 12.2. Gynecological
  • 12.3. Respiratory
  • 12.4. Urological

13. Endoscopy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopy Market

17. China Endoscopy Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Arthrex, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. CONMED Corporation
  • 18.10. Cook Medical LLC
  • 18.11. FUJIFILM Holdings Corporation
  • 18.12. Hoya Corporation
  • 18.13. Intuitive Surgical, Inc.
  • 18.14. Johnson & Johnson
  • 18.15. KARL STORZ SE & Co. KG
  • 18.16. Medtronic plc
  • 18.17. Mindray Medical International Limited
  • 18.18. Olympus Corporation
  • 18.19. Pentax Medical Company
  • 18.20. Richard Wolf GmbH
  • 18.21. Smith & Nephew plc
  • 18.22. STERIS Corporation
  • 18.23. Stryker Corporation
  • 18.24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPY MARKET SIZE, BY USABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPY MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPY MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPY MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPY MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPY MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPY MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPY MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPY MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPY MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPY MARKET SIZE, BY ARTHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPY MARKET SIZE, BY ARTHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPY MARKET SIZE, BY ARTHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY MARKET SIZE, BY LAPAROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY MARKET SIZE, BY LAPAROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPY MARKET SIZE, BY LAPAROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPY MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPY MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPY MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPY MARKET SIZE, BY FIBER OPTIC ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPY MARKET SIZE, BY FIBER OPTIC ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPY MARKET SIZE, BY FIBER OPTIC ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPY MARKET SIZE, BY VIDEO ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPY MARKET SIZE, BY VIDEO ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPY MARKET SIZE, BY VIDEO ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPY MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPY MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPY MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPY MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPY MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPY MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. GCC ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. G7 ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NATO ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)